Protalix BioTherapeutics Inc (FRA:PBDA)
€ 1.32 +0.040 (+3.13%) Market Cap: 107.56 Mil Enterprise Value: 82.33 Mil PE Ratio: 39.50 PB Ratio: 2.73 GF Score: 68/100

Protalix BioTherapeutics Inc (FRA:PBDA) Transcripts

  • 1